These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1079 related articles for article (PubMed ID: 27834397)

  • 1. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia.
    Sperling AS; Gibson CJ; Ebert BL
    Nat Rev Cancer; 2017 Jan; 17(1):5-19. PubMed ID: 27834397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapy.
    Dan C; Chi J; Wang L
    Ann Med; 2015 May; 47(3):209-17. PubMed ID: 25861829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chromosome alterations, genetic mutations and clonal hematopoiesis of indeterminate potential (CHIP) on the classification and risk stratification of MDS.
    Ganguly BB; Banerjee D; Agarwal MB
    Blood Cells Mol Dis; 2018 Mar; 69():90-100. PubMed ID: 29079134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epigenetic dysregulation in myelodysplastic syndrome].
    Sashida G; Iwama A
    Rinsho Ketsueki; 2015 Feb; 56(2):111-8. PubMed ID: 25765789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and Pathogenesis of Myelodysplastic Syndrome.
    Rotter LK; Shimony S; Ling K; Chen E; Shallis RM; Zeidan AM; Stahl M
    Cancer J; 2023 May-Jun 01; 29(3):111-121. PubMed ID: 37195766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high occurrence of acquisition and/or expansion of C-CBL mutant clones in the progression of high-risk myelodysplastic syndrome to acute myeloid leukemia.
    Kao HW; Sanada M; Liang DC; Lai CL; Lee EH; Kuo MC; Lin TL; Shih YS; Wu JH; Huang CF; Ogawa S; Shih LY
    Neoplasia; 2011 Nov; 13(11):1035-42. PubMed ID: 22131879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes.
    Walter MJ; Shen D; Shao J; Ding L; White BS; Kandoth C; Miller CA; Niu B; McLellan MD; Dees ND; Fulton R; Elliot K; Heath S; Grillot M; Westervelt P; Link DC; DiPersio JF; Mardis E; Ley TJ; Wilson RK; Graubert TA
    Leukemia; 2013 Jun; 27(6):1275-82. PubMed ID: 23443460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rise of the Clones: Myelodysplastic Syndrome to Secondary Acute Myeloid Leukemia.
    Romine KA; van Galen P
    Blood Cancer Discov; 2022 Jul; 3(4):270-272. PubMed ID: 35709709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Reversible" myelodysplastic syndrome or ineffectual clonal haematopoiesis? - add(6p) myeloid neoplasm with a spontaneous cytogenetic remission.
    Rady K; Blombery P; Westerman DA; Wall M; Curtis M; Campbell LJ; Seymour JF
    Leuk Res; 2018 Oct; 73():1-4. PubMed ID: 30170269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDS prognostic scoring systems – past, present, and future.
    Jonas BA; Greenberg PL
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):3-13. PubMed ID: 25659725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment.
    Stosch JM; Heumüller A; Niemöller C; Bleul S; Rothenberg-Thurley M; Riba J; Renz N; Szarc Vel Szic K; Pfeifer D; Follo M; Pahl HL; Zimmermann S; Duyster J; Wehrle J; Lübbert M; Metzeler KH; Claus R; Becker H
    Br J Haematol; 2018 Sep; 182(6):830-842. PubMed ID: 29974943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging patterns in clonal haematopoiesis.
    Capo-Chichi JM; Michaels P; Tremblay-Le May R; Abelson S; Hasserjian RP; Xia D
    J Clin Pathol; 2019 Jul; 72(7):453-459. PubMed ID: 31164443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of clonal evolution in myelodysplastic syndromes.
    Makishima H; Yoshizato T; Yoshida K; Sekeres MA; Radivoyevitch T; Suzuki H; Przychodzen B; Nagata Y; Meggendorfer M; Sanada M; Okuno Y; Hirsch C; Kuzmanovic T; Sato Y; Sato-Otsubo A; LaFramboise T; Hosono N; Shiraishi Y; Chiba K; Haferlach C; Kern W; Tanaka H; Shiozawa Y; Gómez-Seguí I; Husseinzadeh HD; Thota S; Guinta KM; Dienes B; Nakamaki T; Miyawaki S; Saunthararajah Y; Chiba S; Miyano S; Shih LY; Haferlach T; Ogawa S; Maciejewski JP
    Nat Genet; 2017 Feb; 49(2):204-212. PubMed ID: 27992414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bone-marrow niche in MDS and MGUS: implications for AML and MM.
    Ghobrial IM; Detappe A; Anderson KC; Steensma DP
    Nat Rev Clin Oncol; 2018 Apr; 15(4):219-233. PubMed ID: 29311715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Patterns of Clonal Evolution Drive Myelodysplastic Syndrome Progression to Secondary Acute Myeloid Leukemia.
    Guess T; Potts CR; Bhat P; Cartailler JA; Brooks A; Holt C; Yenamandra A; Wheeler FC; Savona MR; Cartailler JP; Ferrell PB
    Blood Cancer Discov; 2022 Jul; 3(4):316-329. PubMed ID: 35522837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research progress on mechanism of MDS transformation into AML].
    Wang LL; Gao C; Chen BA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):254-9. PubMed ID: 21362264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal Hematopoiesis and therapy related MDS/AML.
    Desai P; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):13-23. PubMed ID: 30927970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
    Steensma DP; Bejar R; Jaiswal S; Lindsley RC; Sekeres MA; Hasserjian RP; Ebert BL
    Blood; 2015 Jul; 126(1):9-16. PubMed ID: 25931582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic mutation constellations in acute myeloid leukaemia and myelodysplastic syndrome.
    Iacobucci I; Mullighan CG
    Curr Opin Hematol; 2021 Mar; 28(2):101-109. PubMed ID: 33427759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.